Skip to main content
Log in

A survey of iron supplementation, iron status surveillance, and erythropoiesis stimulating agent use in level III NICUs in the United States

  • Brief Communication
  • Published:
Journal of Perinatology Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Data availability

A deidentified data set is available by contacting the corresponding author.

References

  1. Lozoff B, Georgieff MK. Iron deficiency and brain development. Semin Pediatr Neurol. 2006;13:158–65. https://doi.org/10.1016/j.spen.2006.08.004.

    Article  PubMed  Google Scholar 

  2. Widdowson EM, Spray CM. Chemical development in utero. Arch Dis Child. 1951;26:205–14. https://doi.org/10.1136/adc.26.127.205.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Baker RD, Greer FR, Committee on Nutrition American Academy of Pediatrics. Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0–3 years of age). Pediatrics. 2010;126:1040–50. https://doi.org/10.1542/peds.2010-2576.

    Article  PubMed  Google Scholar 

  4. Gisslen T, Rao R, Georgieff MK. Anemia, iron supplementation, and the brain. Clin Perinatol. 2023;50:853–68.

    Article  PubMed  Google Scholar 

  5. Hayashibe H, Asayama K, Dobashi K, Kato K. Prenatal development of antioxidant enzymes in rat lung, kidney, and heart: marked increase in immunoreactive superoxide dismutases, glutathione peroxidase, and catalase in the kidney. Pediatr Res. 1990;27:472–5.

    Article  CAS  PubMed  Google Scholar 

  6. Cohen J, Khudanyan A, Lu J, Wing J, Olson S, Deloughery T, et al. A multicenter study evaluating the effectiveness and safety of single-dose low molecular weight iron dextran vs single-dose ferumoxytol for the treatment of iron deficiency. Am J Hematol. 2020;95:1572–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Brugnara C, Schiller B, Moran J. Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states. Clin Lab Haematol. 2006;28:303–8. https://doi.org/10.1111/j.1365-2257.2006.00812.x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Ohls RK, Schibler KR, Tan S, Lowe JR, Beauman SS, Grisby CA, et al. Darbepoetin (Darbe) trial to improve red cell mass and neuroprotection in preterm infants. In: Oral Platform. Pediatric Academic Societies Meeting, Washington DC, Pediatric Academic Societies, The Woodlands, TX, U.S.A., E-PAS2023: 2150.4. 2023.

Download references

Acknowledgements

The authors thank Dr. Scott Snyder of Boise, ID, for providing the curated list of level III NICUs from which the sample was obtained free-of-charge.

Author information

Authors and Affiliations

Authors

Contributions

JJT, TMB: conception and design, collection and assembly of data, data analysis and interpretation, manuscript writing, editing, and final approval of manuscript. SMT, RDC, RKO: conception and design, manuscript writing, data analysis and interpretation, editing, and final approval of manuscript.

Corresponding author

Correspondence to Timothy M. Bahr.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tuttle, J.J., Bahr, T.M., Tweddell, S.M. et al. A survey of iron supplementation, iron status surveillance, and erythropoiesis stimulating agent use in level III NICUs in the United States. J Perinatol (2024). https://doi.org/10.1038/s41372-024-01950-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41372-024-01950-2

  • Springer Nature America, Inc.

Navigation